Ronghui Zhu il 01/04/2025

Triglyceride-glucose index is a significant predictor of hospital mortality in non-diabetic critically ill patients with ischemic stroke: a retrospective cohort study of the MIMIC-IV database

Acta Diabetol. 2025 Apr 1. doi: 10.1007/s00592-025-02502-6. Online ahead of print.ABSTRACTBACKGROUND AND AIMS: The relationship between the TyG index and outcomes in non-diabetic patients with ischemic stroke admitted to intensive care unit (ICU) has not been validated. This study aims to investigat

Hee Youn Han il 01/04/2025

Predictive association between the γ-glutamyltransferase-high-density lipoprotein cholesterol ratio and all-cause mortality in the Korean genome and epidemiology study: health examinees cohort

Acta Diabetol. 2025 Apr 1. doi: 10.1007/s00592-025-02495-2. Online ahead of print.ABSTRACTOBJECTIVE: The ratio of γ-glutamyl transferase (GGT) and high-density lipoprotein cholesterol (HDL-C) is a novel noninsulin-based marker for assessing the risk of nonalcoholic fatty liver disease and type 2 dia

Christian S Göbl il 01/04/2025

Early prediction of gestational diabetes mellitus: the role of the pregnancy-specific triglycerides-glucose index and other fasting parameters in combination with dynamic testing

Acta Diabetol. 2025 Apr 1. doi: 10.1007/s00592-025-02490-7. Online ahead of print.ABSTRACTThe identification of mothers at risk for gestational diabetes mellitus (GDM) at start of pregnancy may be beneficial to improve perinatal outcomes. This study aims evaluating the predictive performance of fast

Ge-Yao Qi il 01/04/2025

Analysis of postprandial time trends and influencing factors of blood glucose and insulin in type 2 diabetes mellitus (T2DM) with metabolic dysfunction-associated steatotic liver disease (MASLD): a retrospective study based on propensity score matching (PSM)

Acta Diabetol. 2025 Apr 1. doi: 10.1007/s00592-025-02503-5. Online ahead of print.ABSTRACTBACKGROUND: Metabolic dysfunction-associated steatotic liver disease (MASLD) and type 2 diabetes mellitus (T2DM) are increasingly prevalent metabolic disorders worldwide, with a complex bidirectional relationsh

Azharuddin Sajid Syed Khaja il 21/03/2025

Dysregulation and therapeutic prospects of regulatory T cells in type 1 diabetes

Acta Diabetol. 2025 Mar 21. doi: 10.1007/s00592-025-02478-3. Online ahead of print.ABSTRACTType 1 diabetes (T1D) is an autoimmune disease that selectively destroys β-cells in the pancreas that produce insulin. Several studies have implicated and elaborated the significant role of regulatory T cells

Trinity L Brigham il 13/02/2025

Case series of a hybrid closed loop therapy system used in pregnancy

Acta Diabetol. 2025 Feb 13. doi: 10.1007/s00592-025-02469-4. Online ahead of print.ABSTRACTAIMS: The effectiveness of Hybrid Closed-Loop (HCL) therapy is rarely studied in type 1 diabetes (T1D) pregnancies.METHODS: T1D pregnancies (n = 15) managed off-label during gestation using a commercially avai